The peptide carries a fatty di-acid moiety (C20) attached via a -glutamate2OEG linker, which mediates reversible binding to serum albumin and extends its circulating half-life to approximately five days, the basis for once-weekly research dosing protocols
Headache is also reported as an adverse effect in clinical trials of tirzepatide and other drugs in this class, such as semaglutide products (Ozempic and Wegovy) and liraglutide brands (like Saxenda), but individual responses vary
For microdosing, rotate the wheel a few times to select a microdose
The full STEP 18 programme, SUSTAIN cardiovascular data, and several years of NHS real-world prescribing through specialist weight-management services all support it
Or a halved one
Experts say one problem is that temporary use could undermine health by diminishing lean muscle mass, every time a person resumes GLP-1s